| Short Description : | Mouse monoclonal anti-Lp-PLA2 for use in FIA in Human samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications: | FIA |
| Host: | Mouse |
| Reactivity: | Human |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Clonality : | Monoclonal |
| Clone ID : | 11209 |
| Isotype: | IgG1 |
| Conjugation: | Unconjugated |
| Concentration: | 5.0 mg/ml (+/-10 %) |
| Formulation: | 50 mM citrate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative |
| Storage Instruction: | Store at 2–8 °C, and do not freeze. |
| Immunogen: | Not determined |
| Specificity: | Antibody recognizes human lipoprotein-associated phospholipase A2. Not determined |
| Background | Lipoprotein-associated phospholipase A2 (Lp-PLA2) also known as platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme involved in atherosclerosis related vascular inflammation. Increased Lp-PLA2 mass and activity are prognostic biomarkers for cardiovascular disease (CVD) including coronary heart disease and ishcemic stroke. |
Information sourced from Uniprot.org